Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Christina C, Lindenmeyer"'
Autor:
Stephanie N. Bass, PharmD, Mollie Lumpkin, PharmD, Eduardo Mireles-Cabodevila, MD, Christina C. Lindenmeyer, MD, Bridget Dolan, MPAS, Caleigh Pickett, MPAS, Aanchal Kapoor, MD
Publikováno v:
Critical Care Explorations, Vol 3, Iss 5, p e0411 (2021)
OBJECTIVES:. Studies of the use of IV N-acetylcysteine in the management of non-acetaminophen-induced acute liver failure have evaluated various dosing regimens. The only randomized trial studying this application described a 72-hour regimen. However
Externí odkaz:
https://doaj.org/article/59695b5eec494534930bd258a3ceff72
Publikováno v:
Clin Liver Dis (Hoboken)
Content available: Author Interview and Audio Recording.
Publikováno v:
Cleveland Clinic Journal of Medicine. 89:523-533
Autor:
Manik Aggarwal, Rajat Garg, Prabhat Kumar, Christina C. Lindenmeyer, Jamile Wakim-Fleming, Claire Jansson-Knodell, Alberto Rubio-Tapia
Publikováno v:
Digestive Diseases and Sciences. 68:1369-1380
Previous studies have reported conflicting results regarding prevalence of elevated LC (2-70%) in celiac disease (CD). This systematic review and meta-analysis assessed the prevalence of elevated LC at time of CD diagnosis and associated response to
Publikováno v:
Liver Transplantation.
Publikováno v:
Clin Liver Dis (Hoboken)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2475826ac73324b8401b08a11372bd98
https://europepmc.org/articles/PMC10013334/
https://europepmc.org/articles/PMC10013334/
Publikováno v:
World Journal of Hepatology
The multi-organ failure syndrome associated with acute and acute-on-chronic liver failure (ACLF) is thought to be mediated by overwhelming systemic inflammation triggered by both microbial and non-microbial factors. Therapeutic plasma exchange (TPE)
Publikováno v:
Journal of Clinical Gastroenterology. 55:667-676
Acute on chronic liver failure (ACLF) is a unique syndrome that afflicts patients with chronic liver disease and results in high short-term mortality, in the setting of organ system failures. Given this prognosis, there is an urgent need to understan
Autor:
Vedha Sanghi, Tavankit Singh, Mohammad Zmaili, Mohannad Abou Saleh, Carol Rouphael, Motasem Alkhayyat, Carlos Romero-Marrero, Christina C. Lindenmeyer, William D. Carey, C. Roberto Simons-Linares
Publikováno v:
World Journal of Hepatology
Background Sickle cell hepatopathy (SCH) is an inclusive term referring to any liver dysfunction among patients with sickle cell disease. Acute sickle cell intrahepatic cholestasis is one of the rarest and most fatal presentations of SCH. We present
Publikováno v:
Clin Liver Dis (Hoboken)
Content available: Author Audio Recording.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1d250a33282c9fd04680cc0e7e6706e
https://europepmc.org/articles/PMC8958245/
https://europepmc.org/articles/PMC8958245/